402 related articles for article (PubMed ID: 19594786)
1. Access to health and social services for IDU: the impact of a medically supervised injection facility.
Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
[TBL] [Abstract][Full Text] [Related]
2. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
[TBL] [Abstract][Full Text] [Related]
3. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T; Small W; Moore D; Wood E
Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
[TBL] [Abstract][Full Text] [Related]
4. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
Fairbairn N; Small W; Shannon K; Wood E; Kerr T
Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
[TBL] [Abstract][Full Text] [Related]
5. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
Krüsi A; Small W; Wood E; Kerr T
AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
[TBL] [Abstract][Full Text] [Related]
6. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
7. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
8. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
9. IDU perspectives on the design and operation of North America's first medically supervised injection facility.
Small W; Ainsworth L; Wood E; Kerr T
Subst Use Misuse; 2011; 46(5):561-8. PubMed ID: 20874006
[TBL] [Abstract][Full Text] [Related]
10. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.
Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T
Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986
[TBL] [Abstract][Full Text] [Related]
11. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
[TBL] [Abstract][Full Text] [Related]
12. Employment among users of a medically supervised safer injection facility.
Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T
Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450
[TBL] [Abstract][Full Text] [Related]
13. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
[TBL] [Abstract][Full Text] [Related]
14. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics.
Small W; Krusi A; Wood E; Montaner J; Kerr T
Int J Drug Policy; 2012 Mar; 23(2):128-33. PubMed ID: 21885271
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with public injecting among users of Vancouver's supervised injection facility.
McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T
Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555
[TBL] [Abstract][Full Text] [Related]
16. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
Fast D; Small W; Wood E; Kerr T
Harm Reduct J; 2008 Oct; 5():32. PubMed ID: 18957139
[TBL] [Abstract][Full Text] [Related]
17. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
[TBL] [Abstract][Full Text] [Related]
18. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
[TBL] [Abstract][Full Text] [Related]
19. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users.
Neale J; Tompkins C; Sheard L
Health Soc Care Community; 2008 Mar; 16(2):147-54. PubMed ID: 18290980
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.
Wood E; Li K; Palepu A; Marsh DC; Schechter MT; Hogg RS; Montaner JS; Kerr T
Subst Use Misuse; 2005; 40(8):1153-67. PubMed ID: 16040375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
